SG11201608722QA - Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound - Google Patents
Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compoundInfo
- Publication number
- SG11201608722QA SG11201608722QA SG11201608722QA SG11201608722QA SG11201608722QA SG 11201608722Q A SG11201608722Q A SG 11201608722QA SG 11201608722Q A SG11201608722Q A SG 11201608722QA SG 11201608722Q A SG11201608722Q A SG 11201608722QA SG 11201608722Q A SG11201608722Q A SG 11201608722QA
- Authority
- SG
- Singapore
- Prior art keywords
- polymorphs
- salts
- aminopyridine compound
- substituted imidazopyridinyl
- imidazopyridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461982692P | 2014-04-22 | 2014-04-22 | |
| PCT/US2015/027045 WO2015164479A1 (en) | 2014-04-22 | 2015-04-22 | Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201608722QA true SG11201608722QA (en) | 2016-11-29 |
Family
ID=54321420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201608722QA SG11201608722QA (en) | 2014-04-22 | 2015-04-22 | Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9422283B2 (en) |
| EP (2) | EP3134407B1 (en) |
| JP (2) | JP6961348B2 (en) |
| KR (1) | KR20160143842A (en) |
| CN (2) | CN111499627A (en) |
| AU (2) | AU2015249809B2 (en) |
| BR (1) | BR112016024521A2 (en) |
| CA (1) | CA2945778A1 (en) |
| DK (1) | DK3134407T3 (en) |
| ES (1) | ES2745156T3 (en) |
| HU (1) | HUE046150T2 (en) |
| IL (1) | IL248342A (en) |
| MX (2) | MX2016013911A (en) |
| PL (1) | PL3134407T3 (en) |
| PT (1) | PT3134407T (en) |
| RU (1) | RU2732125C2 (en) |
| SG (1) | SG11201608722QA (en) |
| TW (1) | TWI652266B (en) |
| WO (1) | WO2015164479A1 (en) |
| ZA (1) | ZA201607107B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220024617A (en) * | 2019-07-17 | 2022-03-03 | 서밋 (옥스포드) 리미티드 | Process for the preparation of ridinylazole and its crystalline form |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| ATE300540T1 (en) * | 2000-04-27 | 2005-08-15 | Yamanouchi Pharma Co Ltd | IMIDAZOPYRIDINE DERIVATIVES |
| US6403588B1 (en) * | 2000-04-27 | 2002-06-11 | Yamanouchi Pharmaceutical Co., Ltd. | Imidazopyridine derivatives |
| GB0206860D0 (en) * | 2002-03-22 | 2002-05-01 | Glaxo Group Ltd | Compounds |
| EP2251341A1 (en) * | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Heterocyclic Janus kinase 3 inhibitors |
| WO2007111904A2 (en) * | 2006-03-22 | 2007-10-04 | Vertex Pharmaceuticals Incorporated | C-met protein kinase inhibitors for the treatment of proliferative disorders |
| US8136543B2 (en) * | 2009-01-27 | 2012-03-20 | Fisher Controls International, Llc | Axial flow control valves having an internal actuator |
| IT1395963B1 (en) * | 2009-06-04 | 2012-11-02 | Rottapharm Spa | CRYSTALLINE FORMS OF 6- (1H-IMIDAZOL-1-IL) -2-FENYL CHINAZOLIN AND OF ITS SALTS |
| SG181947A1 (en) | 2009-12-30 | 2012-07-30 | Arqule Inc | Substituted imidazopyridinyl-aminopyridine compounds |
| US8815854B2 (en) | 2011-06-24 | 2014-08-26 | Arqule, Inc. | Substituted imidazopyridinyl compounds |
| CA2837727C (en) | 2011-06-24 | 2019-12-03 | Arqule, Inc. | Substituted imidazopyridinyl-aminopyridine compounds |
-
2015
- 2015-04-22 CN CN202010103721.0A patent/CN111499627A/en active Pending
- 2015-04-22 RU RU2016145264A patent/RU2732125C2/en active
- 2015-04-22 PL PL15783385T patent/PL3134407T3/en unknown
- 2015-04-22 HU HUE15783385A patent/HUE046150T2/en unknown
- 2015-04-22 AU AU2015249809A patent/AU2015249809B2/en not_active Ceased
- 2015-04-22 BR BR112016024521A patent/BR112016024521A2/en not_active Application Discontinuation
- 2015-04-22 CA CA2945778A patent/CA2945778A1/en active Pending
- 2015-04-22 EP EP15783385.6A patent/EP3134407B1/en active Active
- 2015-04-22 EP EP19184995.9A patent/EP3653627A1/en not_active Withdrawn
- 2015-04-22 TW TW104112870A patent/TWI652266B/en not_active IP Right Cessation
- 2015-04-22 DK DK15783385.6T patent/DK3134407T3/en active
- 2015-04-22 ES ES15783385T patent/ES2745156T3/en active Active
- 2015-04-22 CN CN201580033637.3A patent/CN106795153B/en not_active Expired - Fee Related
- 2015-04-22 PT PT15783385T patent/PT3134407T/en unknown
- 2015-04-22 KR KR1020167032091A patent/KR20160143842A/en not_active Application Discontinuation
- 2015-04-22 WO PCT/US2015/027045 patent/WO2015164479A1/en active Application Filing
- 2015-04-22 JP JP2016564070A patent/JP6961348B2/en active Active
- 2015-04-22 SG SG11201608722QA patent/SG11201608722QA/en unknown
- 2015-04-22 US US14/693,015 patent/US9422283B2/en active Active
- 2015-04-22 MX MX2016013911A patent/MX2016013911A/en active IP Right Grant
-
2016
- 2016-10-13 IL IL248342A patent/IL248342A/en active IP Right Grant
- 2016-10-14 ZA ZA2016/07107A patent/ZA201607107B/en unknown
- 2016-10-21 MX MX2020009412A patent/MX2020009412A/en unknown
-
2019
- 2019-07-19 AU AU2019206118A patent/AU2019206118B2/en not_active Ceased
- 2019-12-24 JP JP2019232895A patent/JP2020073523A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284874A (en) | Valbenazine salts and polymorphs thereof | |
| IL254351A0 (en) | Acid-addition salt of trk-inhibiting compound | |
| ZA201700880B (en) | Polymorphs of selinexor | |
| EP3116671C0 (en) | Method of forming a compound roll | |
| IL259572B (en) | Salts of tetracyclines | |
| PL3113773T3 (en) | Crystalline forms of grapiprant | |
| HK1247196A1 (en) | Novel salts and polymorphs of scy-078 | |
| EP3107540A4 (en) | Polymorphs of lomitapide and its salts | |
| PL3189045T3 (en) | Novel salts of nilotinib and polymorphs thereof | |
| IL251863A0 (en) | Crystalline forms of ferric maltol | |
| HK1220458A1 (en) | Polymorphs and salts of a compound | |
| ZA201607107B (en) | Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound | |
| HUP1500506A2 (en) | Salts of palbociclib | |
| TWM490349U (en) | Improved structure of a darter | |
| PT3165222T (en) | Use of phthalide compound |